4//SEC Filing
BRYNJELSEN SEAN 4
Accession 0001437749-26-001290
CIK 0001710340other
Filed
Jan 13, 7:00 PM ET
Accepted
Jan 14, 6:04 PM ET
Size
9.9 KB
Accession
0001437749-26-001290
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Tax Payment
Common Stock
[F1][F2][F3]2026-01-01$15.39/sh−5,015$77,181→ 2,889,266 total - Award
Employee Stock Option (Right to Buy)
[F4]2026-01-12+158,046→ 3,047,312 totalExercise: $15.47Exp: 2036-01-11→ Common Stock (158,046 underlying) - Award
Restricted Stock Units
[F5][F6]2026-01-12+100,517→ 3,147,829 total→ Common Stock (100,517 underlying)
Footnotes (6)
- [F1]Shares withheld by the Issuer to satisfy applicable withholding taxes upon the vesting of restricted stock units.
- [F2]The shares were sold in multiple trades at prices ranging from $15.39 to $15.42. The price reported above reflects the weighted average sales price.
- [F3]The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- [F4]The shares subject to the option shall vest in 48 equal monthly installments from the date of grant until fully vested and exercisable on January 12, 2030.
- [F5]Each restricted stock unit represents a contingent right to receive one share of ETON Common Stock.
- [F6]The restricted stock units vest in four equal annual installments beginning January 12, 2027, contingent upon the reporting person being employed by the issuer on the date(s) of vesting.
Signature
/s/ James R. Gruber|2026-01-14
Documents
Issuer
Eton Pharmaceuticals, Inc.
CIK 0001710340
Entity typeother
Related Parties
1- filerCIK 0001669976
Filing Metadata
- Form type
- 4
- Filed
- Jan 13, 7:00 PM ET
- Accepted
- Jan 14, 6:04 PM ET
- Size
- 9.9 KB